## AFL: Aflac Incorporated - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.93 indicates fundamental undervaluation. Quality metrics strong (ROE 16%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($106.00)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Aflac Incorporated $AFL Shares Bought by Invesco Ltd.**
- Source: MarketBeat | 20251205T122333 | Somewhat-Bullish | Relevance: 100%
- Invesco Ltd. increased its stake in Aflac Incorporated (NYSE:AFL) by 16.7% in Q2, acquiring an additional 594,971 shares to own over 4.1 million shares valued at $439.5 million. Other institutional investors also adjusted their positions in Aflac, which has a consensus analyst rating of "Hold" and an average price target of $111.00. The company recently announced an increased quarterly dividend and a share buyback program.

**2. Aflac Incorporated $AFL Position Reduced by First Trust Advisors LP**
- Source: MarketBeat | 20251204T100806 | Somewhat-Bullish | Relevance: 100%
- First Trust Advisors LP reduced its stake in Aflac Incorporated (NYSE:AFL) by 13.1% in the second quarter, selling 582,563 shares and now owning 3,854,930 shares valued at approximately $406.54 million. Despite this reduction, Aflac announced an increase in its quarterly dividend to $0.61 per share and approved a 100,000,000 share buyback program. Analysts currently have an average "Hold" rating on Aflac with a target price of $111.00.

**3. Northwestern Mutual Wealth Management Co. Purchases 10,120 Shares of Aflac Incorporated $AFL**
- Source: MarketBeat | 20251204T040959 | Somewhat-Bullish | Relevance: 100%
- Northwestern Mutual Wealth Management Co. increased its stake in Aflac Incorporated by 12.3% in Q2, acquiring an additional 10,120 shares to own a total of 92,718 shares valued at approximately $9.78 million. Aflac has also announced a quarterly dividend increase to $0.61 and authorized a share buyback program for 100 million shares, indicating a strong commitment to shareholder returns. Analyst ratings for Aflac are currently mixed, with a consensus "Hold" rating and an average price target of $111.

**4. CW Advisors LLC Boosts Stock Position in Aflac Incorporated $AFL**
- Source: MarketBeat | 20251204T101200 | Somewhat-Bullish | Relevance: 99%
- CW Advisors LLC significantly increased its stake in Aflac Incorporated (NYSE:AFL) by 102.3% in the second quarter, bringing its total holdings to 159,722 shares valued at approximately $16.84 million. Aflac has also raised its quarterly dividend to $0.61 per share and authorized a share repurchase plan for up to 100,000,000 shares. Analysts currently have a consensus "Hold" rating on Aflac with an average target price of $111.

**5. Zacks Industry Outlook Highlights Aflac, Unum Group, Globe Life and Trupanion**
- Source: Yahoo Finance | 20251203T143900 | Bullish | Relevance: 93%
- The Zacks Accident and Health Insurance industry is expected to grow due to increased underwriting exposure and demand for supplemental health products, despite challenges like pricing pressure and rising medical costs. Key players like Aflac, Unum Group, Globe Life, and Trupanion are highlighted for their strategic advancements, strong financial performances, and adoption of technology. The industry overall shows weak near-term prospects due to a negative earnings outlook but is leveraging technology and improved claims frequency for long-term growth.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $118 | $113 | +4% |
| 2025-11-07 | Wells Fargo | $109 | $107 | +2% |
| 2025-11-07 | Evercore ISI Gr | $111 | $110 | +1% |
| 2025-11-05 | JP Morgan | $101 | $100 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |
| 2025-11-07 | Wells Fargo | main | Equal-Weight |
| 2025-11-07 | Evercore ISI Gr | main | Underperform |
| 2025-11-05 | JP Morgan | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.18M) |
| Sells | 10 ($3.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Japan Post Holdings : 10.0% (0.0%)
- Vanguard Group Inc: 9.6% (-0.8%)
- Blackrock Inc.: 7.4% (+0.1%)
- State Street Corpora: 4.6% (+0.1%)
- Wells Fargo & Compan: 2.1% (-24.6%)

### Key Risks

1. Insider selling cluster: $3.5M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +2%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Quality metrics strong (margin 24%). Balance sheet: strong liquidity (48.2x). Insider selling cluster ($3.5M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $58.8B |
| Beta | 0.66 |
| 52W Range | $96.95 - $115.84 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 14.8 |
| Current P/E | 14.4 |
| YoY Growth | -2.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -2.6% to -4.0% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). Underperforming sector by 3.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). RSI neutral at 45. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.99% (CS: 18) | Weak |
| RSI_14 | 44.8 | Neutral |
| MACD Histogram | -0.38 | Bearish |
| vs SMA20 | 0.980x | Below |
| vs SMA50 | 0.990x | Below |
| vs SMA200 | 1.025x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $109.28
- **Stop Loss:** $106.00 (3.0% risk)
- **Target:** $115.84 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 304
- **Position Value:** $33,221.12
- **Portfolio %:** 33.22%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-04 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $2.49 | +40.2% |
| 2025Q2 | $1.71 | $1.78 | +4.3% |
| 2025Q1 | $1.67 | $1.66 | -0.8% |
| 2024Q4 | $1.62 | $1.56 | -3.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*